Advanced glycation end products and human diseases
Proteins, lipids, and nucleic acids can undergo non-enzymatic glycation and oxidation, leading to the formation of Advanced Glycation End products (AGEs). These chemically stable compounds accumulate in various tissues over time and are strongly implicated in the pathogenesis of several chronic huma...
Saved in:
| Main Author: | Hamad Abu Zahra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2025-03-01
|
| Series: | Journal of Biological Research |
| Subjects: | |
| Online Access: | https://www.pagepressjournals.org/jbr/article/view/12656 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Glycation End Products in Disease Development and Potential Interventions
by: Yihan Zhang, et al.
Published: (2025-04-01) -
The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
by: Nada H. Aljarba, et al.
Published: (2025-03-01) -
Effects of advanced glycation end products on stem cell
by: Zetai Zheng, et al.
Published: (2024-12-01) -
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study
by: Mohsen Shaygan Tabar, et al.
Published: (2025-02-01) -
The role of advanced glycation end products in patogenesis of diabetic nephropathy
by: A. O. Gavrilova, et al.
Published: (2022-01-01)